New Zealand Regulatory Update
Natural Health Products Bill
The Ministry of Health is developing a standalone Natural Health Products Bill to create a dedicated regulatory framework for natural health products following the repeal of the Therapeutic Products Act 2023.
The bill has not yet been introduced to Parliament and no timeline for its passage has been confirmed.
Our commitment:
FxMed work closely with the Natural Health Alliance (NHA). Together with the NHA, we are committed to ensuring sensible, risk-proportionate legislation.
What can you do?
Throughout the engagement process for the new Bill for Natural Health Products, we encourage you to make your feelings known to any industry organisations that you belong to, your local MPs plus the Minister and their team.
Brief timeline of key regulatory events
Medsafe confirms changes to the classification of vitamin D in New Zealand.
Medsafe has completed its consultation and confirmed that, from 19 August 2026, the maximum amount of vitamin D permitted in a General Sale medicine has increased from 25 micrograms (1,000 IU) to 50 micrograms (2,000 IU) per recommended daily dose.
This change applies to medicines only. The maximum permitted level of vitamin D in dietary supplements remains 25 micrograms (1,000 IU) per recommended daily dose, as the Dietary Supplements Regulations 1985 have not been amended.
The Government announced it will be introducing legislation to amend the Health Practitioners Competence Assurance Act 2003.
Read the press release from Minister of Health, Hon Simeon Brown: Health workforce regulations to put patients first.
The aim of these changes is to ensure health workforce regulation aligns with patient needs, health system priorities and the Government’s health targets.
Next steps
The Ministry of Health will now support the Government with drafting legislation for a bill. The bill is expected to be introduced to Parliament in the months ahead.